Reactivity of FDA-approved anti-D reagents with partial D red blood cells
By: W.J. Judd, M. Moulds and G. Schlanser
Paid access
|May 2020Authors
W.J. Judd
Department of Pathology, University of Michigan, Ann Arbor, MI, United States
M. Moulds
Immunohematology Reference Laboratory ImmucorGamma, Houston, TX, United States
G. Schlanser
Immunohematology Reference Laboratory ImmucorGamma, Houston, TX, United States
DOI: https://doi.org/10.21307/immunohematology-2019-409 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 146 - 148
Published on: May 1, 2020
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
© 2020 W.J. Judd, M. Moulds, G. Schlanser, published by American National Red Cross
This work is licensed under the Creative Commons License.